Children with headache and migraine, particularly girls younger than12 years of age, experience premonitory signs.
The understanding of the mechanisms of allodynia, a frequent migraine comorbidity, is essential to the treatment of both conditions as allodynia can be disabling and may affect the response to migraine treatment.
Concordance or discordance in pain catastrophizing between parents and children may impact pain coping in children with migraine.
Zolmitriptan nasal spray may be beneficial in the treatment of migraines in adolescents.
NINDS program director urged clinicians, researchers, and clinician-scientists to submit grant applications to the NIH, as very few are submitted in the field of migraine and headache research.
Single-pulse transcranial magnetic stimulation may represent an effective prophylactic treatment for migraine.
Erenumab may represent a safe and efficacious prophylactic treatment for episodic migraine.
Children may exhibit different patterns of migraine location and quality compared with adolescents and adults.
Neurology Advisor Articles
- Addressing Rare Headache Disorders: Acute Confusional Migraine
- Organic Solvents Plus Genetics May Increase Risk of Multiple Sclerosis
- No Significant Clinical Differences Between Cluster Headaches With and Without Aura
- Co-Prescription of Opioids and Antidepressants Prevalent in Migraine
- Deep Brain Stimulation May Slow Rest Tremor Progression in Parkinson Disease
- Herpesvirus Abundant in Alzheimer Disease Brain, New Study Finds
- Patients' Preferences for Physician Attire Linked to Perception of Care
- Weighing the Risks of Deep Brain Stimulation
- Grey Matter Atrophy Sequence in Multiple Sclerosis Phenotypes
- Higher Vitamin D Levels Associated With Fewer Lesions in Multiple Sclerosis
- Screening Tool Differentiates Progressive Supranuclear Palsy and Parkinson Disease
- Risk Factors for Impulse Control Behaviors in Parkinson Disease
- Cardiac Pathology in SUDEP Compared With Sudden Arrhythmic or Traumatic Deaths
- 11.2% of U.S. Adults Aged ≥45 Report Subjective Mental Decline
- AMA Aims to Boost Affordability of ACA Marketplace Plans